Physiologic response to a protein, carbohydrate, fat meal in patients with human immunodeficiency virus who underwent small intestinal enteropathy as characterized by a kinetic model of D-xylose absorption

被引:3
作者
Carlson, SJ
Deutsch, JC
Craig, RM
机构
[1] Northwestern Univ, Sch Med, Chicago, IL USA
[2] Univ Colorado, Denver, CO 80202 USA
关键词
D O I
10.1177/014860719802200127
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Purpose: Small intestinal human immunodeficiency virus enteropathy is characterized by profound absorptive dysfunction unrelated to histology or pathogens. Frequently, an attempt is made to compensate for this intestinal failure by supplementing nutrient intake with nourishing liquid meals. It is not known how the diminished absorptive function in these patients will respond to this intake. With the use of a D-xylose kinetic model of absorption, we determined the absorptive response of patients with small intestinal enteropathy to an isotonic liquid feeding. Methods: Seven male patients with acquired immunodeficiency syndrome (AIDS), diarrhea, weight loss, and no detectable pathogens (stool studies and duodenal biopsy) were enrolled. After an overnight fast, the patients were studied on three separate days. On day 1, the patients received 15 g oral D-xylose. On day 2, 10 g IV D-xylose was given. On day 3, 15 g oral D-xylose was again given along with 250 mL of a Liquid polymeric isotonic diet. Serum and urine collections were obtained to calculate the kinetic rate constants and extent of D-xylose absorption. Results: Mean values for the rate constant for absorption of D-xylose, K-a, (0.26/h; N > 0.65) and the rate constant for nonabsorptive loss, (K-0, (2.47/h; N < 0.353) were very abnormal before the meal. Mean K-0 improved (decreased to 0.66), but K-a and bioavailability, F, did not have a statistically significant change after the meal. The improvement in mean K-0 with the meal was much more pronounced in the five subjects with high K,values before the meal (without meal 3.22; with meal 0.67; p < .05). Conclusions: (1) An isotonic liquid polymeric diet leads to less nonabsorptive loss of D-xylose, but does not affect the extent of D-xylose absorption in this group as a whole. This is probably due to the meal slowing gastric emptying. (2) Improvement in nonabsorptive loss with a meal is most pronounced when there is excessive nonabsorptive loss, K-0, without a meal. (3) Improvement in nonabsorptive losses with a meal might predict which patients will benefit from antimotility agents and continued feedings vs those requiring IV hyperalimentation.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 14 条
[1]   AUTONOMIC DENERVATION IN JEJUNAL MUCOSA OF HOMOSEXUAL MEN INFECTED WITH HIV [J].
BATMAN, PA ;
MILLER, ARO ;
SEDGWICK, PM ;
GRIFFIN, GE .
AIDS, 1991, 5 (10) :1247-1252
[2]  
BERMAN M, 1967, US PHS PUBLICATION, V1703
[3]   D-XYLOSE HYDROGEN BREATH TESTS COMPARED TO ABSORPTION KINETICS IN HUMAN PATIENTS WITH AND WITHOUT MALABSORPTION [J].
CARLSON, S ;
CRAIG, RM .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (10) :2259-2267
[4]  
CARLSON S, 1994, J LAB CLIN MED, V124, P652
[5]  
CHAVE JP, 1994, AM J GASTROENTEROL, V89, P2168
[6]   INVESTIGATION OF SEEMINGLY PATHOGEN-NEGATIVE DIARRHEA IN PATIENTS INFECTED WITH HIV-1 [J].
CONNOLLY, GM ;
FORBES, A ;
GAZZARD, BG .
GUT, 1990, 31 (08) :886-889
[7]  
EBERTS TJ, 1979, CLIN CHEM, V25, P1440
[8]   MALABSORPTION AND DEFICIENCY OF VITAMIN-B-12 IN HIV-INFECTED PATIENTS WITH CHRONIC DIARRHEA [J].
EHRENPREIS, ED ;
CARLSON, SJ ;
BOORSTEIN, HL ;
CRAIG, RM .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (10) :2159-2162
[9]   HISTOPATHOLOGIC FINDINGS OF DUODENAL BIOPSY SPECIMENS IN HIV-INFECTED PATIENTS WITH AND WITHOUT DIARRHEA AND MALABSORPTION [J].
EHRENPREIS, ED ;
PATTERSON, BK ;
BRAINER, JA ;
YOKOO, H ;
RADEMAKER, AW ;
GLOGOWSKI, W ;
NOSKIN, GA ;
CRAIG, RM .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 97 (01) :21-28
[10]   KINETICS OF D-XYLOSE ABSORPTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENTEROPATHY [J].
EHRENPREIS, ED ;
GULINO, SP ;
PATTERSON, BK ;
CRAIG, RM ;
YOKOO, H ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) :632-640